Latest filing published 11 Mar 2022 for Anika Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Thomas Finnerty: trading record in brief
Thomas Finnerty is a declared insider of Anika Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 17 filings, for trades running from 30 October 2017 to 9 March 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 11 March 2022 with a share grant (€18k) in Anika Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas Finnerty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,548 shares0Common StockSEC:0001171843-22-001811:0
- 2,834 shares0Common StockSEC:0001171843-22-001459:0
- 10,125 shares0Common StockSEC:0001171843-22-000984:0
3 of 3 declarations
